Contract 75N93020C00055
Biocryst Pharmaceuticals Inc · Department Of Health And Human Services · August 19, 2024
Biocryst Pharmaceuticals Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 19, 2024 for $2.61 million (current value) of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Durham, NC. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost-plus contract pricing. The most recent modification was on August 19, 2024. If all options are exercised, the contract could reach $40.20 million.
Contract details
- PIID
- 75N93020C00055
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- General Science And Technology R&D Services; General Science And Technology; Applied Research
- Place of performance
- Durham, NC
- First action
- August 19, 2024
- Latest action
- August 19, 2024
Description
EXTEND PERIOD OF PERFORMANCE FOR THE BASE TILL SEPTEMBER 30, 2022. (NOTE: THE MODIFICATION P00003 IS MODIFICATION P00002 IN THE NBS SYSTEM, MODIFICATION P00004 IS MODIFICATION P00003 IN THE NBS SYSTEM AND THESE ARE CLARIFICATIONS FOR AUDIT PURPOSES
Modification timeline
-
August 19, 2024Mod P00004 · Other Administrative Action$2.61M
-
August 19, 2024Mod P00005 · Close OutTO DE-OBLIGATE REMAINING FUNDS AND ADMINISTRATIVELY CLOSE THE CONTRACT.$2.61M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| The Emmes Company, Llc | Department Of Health And Human Services | April 1, 2026 | $771.5K |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $327.13M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $8.00M |
| Lovelace Biomedical Research Institute | Department Of Health And Human Services | April 1, 2026 | $680.2K |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $9.22M |
| The Brain Donor Project, Inc | Department Of Health And Human Services | April 1, 2026 | $1.27M |
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $2.75B |
| 2 | California Institute Of Technology | 240 | $979.40M |
| 3 | The Johns Hopkins University Applied Physics Laboratory Llc | 204 | $482.74M |
| 4 | Lockheed Martin Corporation | 4 | $461.91M |
| 5 | Lockheed Martin Corp | 9 | $317.27M |
| 6 | The Aerospace Corporation | 85 | $308.18M |
| 7 | Fermi Forward Discovery Group, Llc | 1 | $289.92M |
| 8 | Lockheed Martin Corp | 7 | $285.45M |
| 9 | Amentum Technology, Inc. | 4 | $253.24M |
| 10 | The Mitre Corporation | 50 | $222.51M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93020C00055?
Contract 75N93020C00055 is a federal contract awarded to Biocryst Pharmaceuticals Inc by Department Of Health And Human Services on August 19, 2024 for $2.61 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75N93020C00055?
Biocryst Pharmaceuticals Inc won contract 75N93020C00055 from Department Of Health And Human Services.
How much is contract 75N93020C00055 worth?
Contract 75N93020C00055 has obligated $0 to date but carries a potential ceiling of $40.20 million if fully funded and all options are exercised.